Suchergebnisse - "Bauer, Sebastian"

PubPharm (20)

1

Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Gelderblom, H. | Jones, R. | Blay, J. | +26

2

Genome-wide Association Study Identifies 2 New Loci Associated With Anti-NMDAR Encephalitis

enthalten in: Neurology(R) neuroimmunology & neuroinflammation | 2021

von Tietz, A. | Angstwurm, K. | Baumgartner, T. | +127

3

Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas

enthalten in: Cancer | 2021

von Schaefer, I. | Lundberg, M. | Demicco, E. | +12

4

Pexidartinib Long-Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors

enthalten in: The oncologist | 2021

von Lewis, J. | Gelderblom, H. | van de Sande, M. | +12

5

The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey : a prospective multicenter study

enthalten in: Orphanet journal of rare diseases | 2021

von Bernthal, N. | Spierenburg, G. | Healey, J. | +15

6

Resistance to Avapritinib in PDGFRA-Driven GIST Is Caused by Secondary Mutations in the PDGFRA Kinase Domain

enthalten in: Cancer discovery | 2021

von Grunewald, S. | Klug, L. | Mühlenberg, T. | +16

CommentOn: Cancer Discov. 2021 Jan;11(1):1-3. - PMID 34003778

7

Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

enthalten in: British journal of cancer | 2019

von Serrano, C. | Mariño-Enríquez, A. | Tao, D. | +16

CommentIn: Br J Cancer. 2019 Mar;120(6):577-578. - PMID 30792534

8

MAX inactivation is an early event in GIST development that regulates p16 and cell proliferation

enthalten in: Nature communications | 2017

von Schaefer, I. | Wang, Y. | Liang, C. | +21

9

Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway

enthalten in: Oncotarget | 2015

von Murali, R. | Chandramohan, R. | Möller, I. | +22

10

Inhibition of KIT-glycosylation by 2-deoxyglucose abrogates KIT-signaling and combination with ABT-263 synergistically induces apoptosis in gastrointestinal stromal tumor

enthalten in: PloS one | 2015

von Mühlenberg, T. | Grunewald, S. | Treckmann, J. | +4